Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
31.54
+0.64 (+2.06%)
Streaming Delayed Price
Updated: 11:06 AM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
57,533
Open
31.10
Bid (Size)
31.47 (1)
Ask (Size)
31.57 (4)
Prev. Close
30.90
Today's Range
31.10 - 31.62
52wk Range
18.61 - 39.27
Shares Outstanding
56,791,861
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
April 30, 2024
HRMY earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
HRMY Stock Earnings: Harmony Biosciences Beats EPS, Misses Revenue for Q1 2024
April 30, 2024
HRMY stock results show that Harmony Biosciences beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+2.42%
+2.42%
1 Month
+5.68%
+5.68%
3 Month
+4.01%
+4.01%
6 Month
+26.49%
+26.49%
1 Year
-12.52%
-12.52%
More News
Read More
Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
April 30, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Key Takeaways From Harmony Biosciences Analyst Ratings
April 30, 2024
Via
Benzinga
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
April 30, 2024
From
Harmony Biosciences
Via
GlobeNewswire
Evaluating Harmony Biosciences: Insights From 8 Financial Analysts
March 28, 2024
Via
Benzinga
Analyst Ratings For Harmony Biosciences
February 22, 2024
Via
Benzinga
NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
January 10, 2024
Via
Chartmill
Updates: HRMY, MELI, SWAV
February 28, 2024
Via
Talk Markets
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
February 22, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 22, 2024
From
Harmony Biosciences
Via
GlobeNewswire
The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
February 12, 2024
Via
InvestorPlace
The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
February 07, 2024
Via
InvestorPlace
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts
January 02, 2024
Via
Benzinga
NASDAQ:HRMY: good value for what you're paying.
January 25, 2024
Via
Chartmill
Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents.
January 03, 2024
Via
Chartmill
Why Harmony Biosciences Stock Got Slammed Today
January 02, 2024
Via
The Motley Fool
2023 Year In Review
January 02, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
NASDAQ:HRMY is showing good growth, while it is not too expensive.
December 18, 2023
Via
Chartmill
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
Via
InvestorPlace
NASDAQ:HRMY, an undervalued stock with good fundamentals.
December 13, 2023
Via
Chartmill
Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On
December 07, 2023
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
November 27, 2023
Via
Chartmill
NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying.
November 22, 2023
Via
Chartmill
While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable.
November 03, 2023
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.